Bristol-Myers Squibb Company Ce ( CELG-RI) - Key Metrics
CELG-RI Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | ? | ? | ? | ? |
| 2025Q2 | ? | ? | ? | ? |
| 2025Q1 | ? | ? | ? | ? |
CELG-RI Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | ? |
| 2025Q2 | ? | ? |
| 2025Q1 | ? | ? |
CELG-RI Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 319.80% | ? |
| 2025Q4 | 1095.72% | ? |
| 2025Q3 | 8863.06% | ? |
| 2025Q2 | 6989.68% | ? |
| 2025Q1 | 1668.14% | ? |
CELG-RI
Price: $0.12
52 week price:
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 263.9 million